bbooystock
Posted - 16 hours ago
$AFIB Actually I will wait until maybe 60-75 cents to mention it on podcast like everyone else does
bbooystock
Posted - 17 hours ago
$AFIB In My Med-tech podcast I may mention Afib and Medtronic next week
bbooystock
Posted - 19 hours ago
$AFIB Posters here want to keep quiet-get it
bbooystock
Posted - 21 hours ago
$AFIB The "earnouts for the next 4-5 years are guaranteed from Medtronic. There are $25 million in milestones from MDT "earnouts x 5 years, from Medtronic guaranteed, Atrial ablation company for sale to get over $1 a share, and the crown jewel Left sided transeptal catheter business to be sold at end of five years to highest bidder. Also all the 150 patents, manufacturing plants, FDA approvals and so on to be sold., I heve never seen such a golden opportunity to make 25-30x your money ever in 40 years of Med-tech analysis. Insiders will continue to accumulate and then tell you we are selling company to either Medtronic or Boston Scientific or JNJ for $3+share . Current market cap is $2.25 million and most investors will pay over $1.50, as noone folllows or heard of co.
MrMaxxxx
Posted - 21 hours ago
$AFIB The spread between bid/ask tells the story.
The MM are trying to get penny flippers out,
I am holding.
Higher highs and higher lows are coming.
bbooystock
Posted - 21 hours ago
$AFIB I predict most investors will pay over $1 a share as insiders buy up all stock
bbooystock
Posted - 21 hours ago
$AFIB My investigation revealed that Acutus is manufacturing about 75 catheter systems for Medtronic Here are the leaders:1. FlexCath Cross 2.AcQCross: a line of septal crossing devices 3.AcQGuide Mini 3.AcQGuide Flex 4.AcQGuide Vue Acutus owns 150 patents for the ablation and transeptal and left atrial catheter systems. Medtronic needs Acutus for manufacturing the next 5 years. Then Acutus will sell remaining business to Medtronic at fair value with premium. All Acutus catheter systems of course are FDA approved and in good manufacturing practices with Acutus owning the factories for production. Acutus is owed up to $30 million in milestones from Medtroic. Meantime Acutus is soliciting bids for abation business which should fetch over $1 a share . This does not include the $25 million in restricted cash, the "Earnouts", and the crown jewel or Left transeptal caheter business. Amazingly at 8 cents, biggest value stock I haver ever seen in 40 years of Med-tech analysis.
bbooystock
Posted - 1 day ago
$AFIB My detailed investigation reveals its hard to believe this share is at $7-8 cents. 1. Alblation business worth over $1 a share 2. Left catheter earnouts will be over $1.1 a share 3. Acutus has 150 patents on catheters 4.Still $30 million in milestones 5. $25 million in restricted cash 6. Medtronic catalogue has 13 pages devoted to Acutus catheters that Acutus manufactures fro Medtronic 7. Left catheter business still has value to be sold with Medtronic or Boston Scientific the most likely acquirers 8, All for $7-8 cents unbelievable. In short term Mr market id inefficient. In mid - longer term Market very efficient 9. In meantime company insiders buying lots of shares
MrMaxxxx
Posted - 1 day ago
$AFIB Some DD,
Enterprise value $24.7 million Market cap $2.34 million. Shares outstanding 29.7 million shares Float is 27.01 million shares 9.01% of the shares are held by insiders.
Insiders are not selling.
Shorted shares were 984,000 shares. Since 05/03/24, when they started trading on OTC there has been 28.01 million have traded.
There is no dilution happening. No toxic financing going on. No pump, just facts. All the above numbers are from Yahoo finance.
bbooystock
Posted - 1 day ago
$AFIB My prediction only. Insiders will continue to buy shares. They will sell company to medtronic for $2.50 + a share. There is 25 million in restricted cash. Between the restricted cash and the earnouts , the company pays for itself, and you get the catheter ablation business and the Left sided catheter business for free too,. I have never seen such a favorable market situation for the small investor at 9 cents a share to make 25-30x investment
bbooystock
Posted - 1 day ago
$AFIB The is worth $3millionhttps://www.medtronic.com/content/dam/medtronic-wide/public/united-states/products/cardiac-vascular/cardiac-rhythm/introducer-sheaths-needles/flexcath-cross-brochure.pdfalone
bbooystock
Posted - 1 day ago
$AFIB FlexCath Cross™ transseptal solution For transseptal access The FlexCath Cross™ system is an integrated transseptal solution with a zero exchange workflow and pairs with commercially available sheaths for both mechanical and radiofrequency (RF) crossing. Download brochure (opens new window) FlexCath Cross™ transseptal solution system Indications, Safety, and Warnings Overview The first and only transseptal access system specifically engineered to pair with commercially available sheaths, including the Medtronic FlexCath Contour™ steerable sheath. The FlexCath Cross™ system enables a zero exchange transseptal workflow, which adds efficiencies and simplifies left atrial access procedures. FlexCath Cross™ is the only transseptal access system on the market cleared for both mechanical and RF crossing. Product benefits
bbooystock
Posted - 1 day ago
$AFIB I have been medical analyst for 40 years. In AFib i have never seen a share at .08 cents that is currently worth 30x current market price. Afib has all the patents and Fda approvals for all products. Peter Lynch 30 bagger
bbooystock
Posted - 1 day ago
$AFIB the current market cap is $2.1 million.The earnouts are over $1. or $30 million. The milestones are $100 million. Wow
bbooystock
Posted - 1 day ago
$AFIB Insiders will buy up all shares and then sell them to medtronic for huge profit. Same old.........
bbooystock
Posted - 1 day ago
$AFIB I believe insiders are buying up shares and will sell to medtronic for huge profit
Robsonic
Posted - 1 day ago
$AFIB Hello guys I have a question for you . As I own Acutus shares,over 80,000 . But I am stuck with them with my broker who does not support OTC market . I tried to do a transfer to other brokers ( Freedom24 , Saxo Bank ) but they refuse to accept these shares . Honestly whether I want to or not I have become a holder of shares with which I can do nothing . At Saxo Bank they said it is not up to them but Acutus . I am curious about your point of view . What do you think about it .Because I get the impression that they are the ones who started buying up their shares and the rest of the people got rid of under pressure to close their positions . But the price is going up so there is a trade going on somewhere , except I have no idea where .
bbooystock
Posted - 1 day ago
$AFIB The sale of the ablation business will be over $1 a share. Medtronic or Boston Scientific could buy the Left catheter business for free by buying whole co and selling the ablation business and still make $50 million and get Left catheter business for free. In short term market doesnt make sense at 8 cents. However MDT or some other med tech will easily figure this out and steal AFIB for $2 + a share and get for free. Wont stay under $1.50 for long which is 20-30 bagger at 8 cents
bbooystock
Posted - 1 day ago
$AFIB The first major milestone amounted to gross proceeds of $20 million. As of the first milestone payment, Acutus remains eligible for additional milestone payments of 100 million in milestones. These potential payments relate to certain regulatory activities, as well as four to five years of revenue-based earnouts. Acutus’ left-heart access portfolio includes its AcQCross line of sheath-compatible septal crossing devices. It also features the AcQGuide Mini integrated crossing device and sheath. Additionally, it includes the AcQGuide Flex steerable introducer with transseptal dilator and needle and the AcQGuide Vue steerable sheath.
bbooystock
Posted - 1 day ago
$AFIB The Atrial ablation systems are still made by Acutus for Medtronic also FlexCath Cross™ transseptal solution For transseptal access The FlexCath Cross™ system is an integrated transseptal solution with a zero exchange workflow and pairs with commercially available sheaths for both mechanical and radiofrequency (RF) crossing. Download brochure (opens new window)
bbooystock
Posted - 1 day ago
$AFIB Medtronic buys about $22 million a year in Left sided catheters from Acutus. Current market cap is $ 2.1 million which includes $25 million in restricted cash and Atrial ablation business worh about $1 a share. Only a matter of time until Medtronic pays about $50-60 million for whole business. This is $2.50 a share. Who says the market in short term is efficient at 8 cents?
bbooystock
Posted - 1 day ago
$AFIB There are only 30 million shares. $25 million in restricted cash. The earnouts are over 13 cents for first 6 months this year and 25 cents projected this first year. Medtronic must buy company as Acutus owns all the 150 patents to produce for medtronic's catheter business. My investigation also found out that Medtronic has pages and pages devoted to Acutus Medical AcQCross, AcQGuide, AcQGuide Flex, AcQGuide Vue catheter systems that Afib produced for Medtronic
bbooystock
Posted - 1 day ago
$AFIB Currently at 8 cents market pricing co as if bankrupt., In reality the earnouts for next 4 years will exceed $1. The Atrial ablation business is on selling block and could fetch over $1.50 a share. The Left sided catheter business with ver 150 patents is worth over $1.50 to a company like Medtronic. Total value is over $3 a share compared to current 8 cents.
bbooystock
Posted - 1 day ago
$AFIB At .08 cents we get the ablation business for free. The earnouts will exceed 25 cents this year alone. Then earnouts for next 4 years will exceed $1.0. Then the Left sided catheter business will be sold with 150 patents. Goldmine
MrMaxxxx
Posted - 1 day ago
$AFIB This always starts with low volume.
Put in stop loss orders and watch how fast you will lose money.
bbooystock
Posted - 1 day ago
$AFIB Medtronic needs Acutus to produce the Left sided catheter businesss. Acutus owns over 150 patents on it
bbooystock
Posted - 2 days ago
$AFIB 1.The atrial ablation business is in the process of being sold and could fetch over $40 million or $1.33 a share. 2.The earnouts from the Left catheter business which Acutus has about 150 patents are over $.25 a year. 3.The valuation of the Left catheter business which is the crown jewel of the company is over $40 million or $1.33 a share. At sp of .09 cents it is priced as crazily indervalued and shares could be a 20-30 bagger.
bbooystock
Posted - 2 days ago
$AFIB Some traders must have found out that AFib owns all the patents for the Medtronic catheters that they manufacture